⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
From Bench to Breakthrough: Empowering the Next Generation of Science Communicators
accessnewswire.com
MRK
Evexta Bio annonce une collaboration clinique et un contrat d'approvisionnement avec Roche afin d'évaluer le rupitasertib en association avec un dégradateur sélectif des récepteurs des œstrogènes dans le cancer du sein avancé ou métastatique
businesswire.com
MRK
Single-use Technologies for Biopharmaceuticals Market to Reach $16.31 Billion by 2031, Driven by Growing Monoclonal Antibody Production
globenewswire.com
TMO
MRK
Peripheral Artery Disease Clinical Trial Pipeline Expands as 17+ Companies Race to Redefine Peripheral Artery Disease Treatment Landscape | DelveInsight
globenewswire.com
CLRS
MDT
PHG
BSX
BDX
BIOT
ABT
ANGI
RMAX
MRK
SNY
JNJ
BA
GSK
AZN
PFE
NVO
AMGN
VRTX
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
prnewswire.com
MRK
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
prnewswire.com
JNJ
MRK
TEVA
LLY
ABBV
PFE
AZN
Healthcare M&A Deal Volume Drops in Q2:26, According to Acquisition Data from LevinPro HC
globenewswire.com
MRK
NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC
prnewswire.com
MRK
Global Radiopharmaceutical CDMO Market to Accelerate Substantially at a CAGR of ~10% by 2034 | DelveInsight
globenewswire.com
TMO
MRK
DHR
LNT
THC
GEHC
NVS
LLY
AZN
Merck Announces Fourth-Quarter 2026 Dividend
businesswire.com
MRK